Sign in
4

Changes in Ownership

Climb Bio, Inc. Filed Acc 0001193125-26-054568

Director sold 100,000 shares at an average $5.29 ($529,129)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Thomas Stephen Basil · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-12 Sale : show line 1 in the form 10b5-1 −90,000 $5.23 $470,988 214,657 D
2026-02-13 Sale : show line 2 in the form 10b5-1 −10,000 $5.81 $58,141 204,657 D
Open-market sales · 100,000 sh · avg $5.29 · $529,129
Loading xslF345X05/ownership.xml…